Genenta Science name change fails shareholder vote

The proposal received 53,307,711 votes in favor, but approval required more than half of all the company’s voting rights.

Rhea-AI Filing Summary

Genenta Science S.p.A. (GNTA) shareholders did not approve a proposed by-law amendment to change the company’s legal name to Saentra Forge S.p.A. At the October 8, 2026 meeting, 53,307,711 votes were in favor, 20,776,225 were against, and 24,431,835 abstained. Votes in favor represented approximately 54.11% of voting rights represented at the meeting, but approval on first call required a favorable vote of more than 50% of the company’s total voting rights. The company’s registered legal name therefore remains Genenta Science S.p.A.

Genenta says it continues pursuing its previously announced transition to become an industrial consolidator focused on acquiring established public or privately held businesses.

Key Figures

Votes in favor: 53,307,711 votes Votes against: 20,776,225 votes Abstentions: 24,431,835 votes +2 more

5 metrics

Votes in favor 53,307,711 votes Proposed corporate name change

Votes against 20,776,225 votes Proposed corporate name change

Abstentions 24,431,835 votes Proposed corporate name change

Total votes represented 98,516,262 votes Approximately 91.285% of total voting rights represented at the meeting

Shareholders present or represented 28 shareholders October 8, 2026 meeting

Key Terms

Extraordinary Shareholders’ Meeting, first call, total voting rights, industrial consolidator

4 terms

Extraordinary Shareholders’ Meeting regulatory

"held an Extraordinary Shareholders’ Meeting"

An extraordinary shareholders’ meeting is a special gathering called outside the regular annual meeting to vote on urgent or significant company matters, such as large mergers, major asset sales, changes to control, or amendments to governing rules. Think of it as a town-hall called when something important arises that owners must approve; investors should pay attention because outcomes can change a company’s strategy, value, or their ownership stakes quickly.

first call regulatory

"Since the Meeting was held on first call"

The first call is the initial public estimate or report about a company’s upcoming financial results or prospects, usually issued by an analyst or research firm when they start covering the company or after a new quarter begins. It matters to investors because it sets an early benchmark or expectation—like the first score reported in a game—that subsequent estimates, market reactions and consensus numbers are compared against.

total voting rights regulatory

"more than 50% of the Company's total voting rights"

The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.

industrial consolidator technical

"to become an industrial consolidator"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Did GNTA shareholders approve the proposed name change?

No. The proposal to change Genenta Science S.p.A.’s legal name to Saentra Forge S.p.A. was not approved. It received 53,307,711 votes in favor and 20,776,225 against.

Why did GNTA’s proposed name change fail?

Approval on first call required a favorable vote of more than 50% of Genenta’s total voting rights. Votes in favor represented approximately 54.11% of the voting rights represented at the meeting, and the required threshold was not reached.

Which sectors is Genenta targeting under its industrial-consolidator transition?

Genenta says it continues pursuing a transition focused on acquiring established public or privately held businesses in aerospace, defense, biotechnology/biosecurity, and related technologies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 04:05 PM EDT Accepted by SEC EDGAR 10/13/2026 - 04:05 PM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-41115

GENENTA SCIENCE S.P.A.

(Translation of registrant’s name into English)

Via dell’Annunciata 31

20121 Milan, Italy

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

This Report on Form 6-K is incorporated by reference into the registrant’s registration statement on Form S-8 (File No. 333-278392).

Other Events

Results of Extraordinary Shareholders’ Meeting

On October 8, 2026, Genenta Science S.p.A. (the “Company”) held an Extraordinary Shareholders’ Meeting (the “Meeting”) in virtual meeting format. The Meeting constituted a continuation of the previously convened extraordinary shareholders’ meeting, to consider a proposed amendment to Article 1 of the Company’s by-laws to change its corporate name from Genenta Science S.p.A. to Saentra Forge S.p.A.

At the Meeting, 28 shareholders were present or represented, holding an aggregate of 38,811,108 ordinary shares of the Company, representing approximately 80.49% of the Company’s outstanding share capital and an aggregate of 98,516,262 votes, representing approximately 91.28% of the Company’s total voting rights.

The results of the shareholder vote on the proposed corporate name change were as follows:

Voting Result		Number of Votes				% of Total Voting Rights
Votes in favor			53,307,711				49.395	%
Votes against			20,776,225				19.251	%
Abstentions			24,431,835				22.638	%
Not Voting			491				0.000	%
Total represented			98,516,262				91.285	%

The number of votes in favor of the proposal represented approximately 54.11% of the voting rights represented at the Meeting and approximately 71.96% of the number of votes cast for or against the proposal.

Although the proposed amendment received more votes in favor than against, it was not approved. Since the Meeting was held on first call, approval of the proposal required, under Italian law and the Company's Articles of Association, the favorable vote of more than 50% of the Company's total voting rights, rather than a majority of the voting rights represented at the Meeting. This threshold was not reached. Accordingly, the Company’s registered legal name remains Genenta Science S.p.A.

Notwithstanding the outcome of the shareholder vote, the Company continues to pursue its previously announced strategic transition to become an industrial consolidator focused on acquiring established, public or privately held businesses operating in strategic industrial sectors, including aerospace, defense, biotechnology/biosecurity, and related technologies.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GENENTA SCIENCE S.P.A.
	By:	/s/ Pierluigi Paracchi
	Name:	Pierluigi Paracchi
	Title:	Chief Executive Officer

Dated: October 13, 2026